Lv5
1530 积分 2023-08-03 加入
A phase 2 multicenter, open-label, randomized, controlled trial in patients with stage II/III colorectal cancer who are ctDNA positive following resection to compare efficacy of autogene cevumeran versus watchful waiting
1天前
求助中
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
1天前
待确认
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
2天前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
2天前
已完结
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
4天前
已完结
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
4天前
已完结
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
4天前
已完结
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
4天前
已完结
皖公网安备34019202002308
